Abiomed, Inc. / Fundamentals
Income statement
- Net revenue
€925.39M - Cost of goods sold
€172.82M - Gross profit
€752.57M - SG&A expenses
€389.57M - R&D expenses
€144.07M - EBITDA
€244.85M - D&A
€23.74M - EBIT
€218.50M - Interest expenses
€81.19M - EBT
€293.93M - Tax expenses
€64.10M - Net income
€229.83M
Cash flow statement
- Net deferred tax
-€11.37M - Non-cash items
-€52.24M - Changes in working capital
-€20.04M - Operating cash flow
€216.23M - Capex
€29.09M - Other investing cash flow
€0.00 - Net investing cash flow
-€140.36M - Total cash dividends paid
€0.00 - Issuance of common stock
€8.92M - Debt repayment
€0.00 - Other financing cash flow
-€116.77M - Net financing cash flow
-€116.77M - Foreign exchange effects
-€10.41M - Net change in cash
-€51.30M - Cash at end of period
€157.09M - Free cash flow
€245.32M
Balance sheet
- Cash and cash equivalents
€157.09M - Cash and short-term investments
€706.79M - Total receivables
€81.39M - Inventory
€88.08M - Other current assets
€39.38M - Total current assets
€915.65M - Property, plant & equipment
€174.64M - Goodwill
€62.86M - Intangible assets
€43.19M - Long-term investments
€249.04M - Other non-current assets
€0.00 - Total non-current assets
€546.00M - Total assets
€1.46B - Accounts payable
€30.21M - Short-term debt
€0.00 - Other current liabilities
€60.45M - Total current liabilities
€115.50M - Long-term debt
€0.00 - Deferred tax liabilities
€593.61K - Other non-current liabilities
€18.96M - Total non-current liabilities
€19.55M - Total liabilities
€135.05M - Common stock
€389.42K - Retained earnings
€969.41M - Other equity
-€40.19M - Total equity
€1.33B - Total liabilities and shareholders' equity
€1.46B
Company information
- Market capitalization
€14.65B - Employees
2K - Enterprise Value
€17.05B
Company ratios
- Gross margin
-
81.3% Much better than peer group: -16.4% - EBITDA margin
-
26.5% Much better than peer group: -177.2% - EBIT margin
-
23.6% Much better than peer group: -185.4% - EBT margin
-
31.8% Much better than peer group: -158.5% - Net margin
-
24.8% Much better than peer group: -186.8% - ROE
-
17.3% Better than peer group: 7.8% - ROA
-
15.7% Better than peer group: 2.6% - Asset turnover
-
63.3% Worse than peer group: 70.8% - FCF margin
-
20.2% Much better than peer group: -140.2% - FCF yield
1.3% - Efficiency ratio
73.5% - Net sales per employee
-
€462.00K - Net income per employee
-
€114.74K